Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SDZ-62-434 is a platelet-activating factor inhibitor with antitumor activity that inhibits bombesin- and platelet-derived growth factor-induced DNA synthesis in quiescent Swiss 3T3 cells for the study of leukemia, human xenograft colorectal cancer, and lung cancer.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 67,500 |
5 mg | 在庫あり | ¥ 166,000 |
10 mg | 在庫あり | ¥ 226,500 |
25 mg | 在庫あり | ¥ 349,000 |
50 mg | 在庫あり | ¥ 454,500 |
説明 | SDZ-62-434 is a platelet-activating factor inhibitor with antitumor activity that inhibits bombesin- and platelet-derived growth factor-induced DNA synthesis in quiescent Swiss 3T3 cells for the study of leukemia, human xenograft colorectal cancer, and lung cancer. |
別名 | SDZ 62 434, SDZ62434 |
分子量 | 416.39 |
分子式 | C23H27Cl2N3 |
CAS No. | 115621-95-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SDZ-62-434 115621-95-9 Others Platelet aggregation SDZ-62434 SDZ 62 434 SDZ62434 SDZ 62434 Inhibitor inhibitor inhibit